New study tests Extended-Release paliperidone for schizophrenia in bangladesh
Disease control
Not yet recruiting
This study will test the safety and effectiveness of paliperidone extended-release tablets in 505 adults with schizophrenia in Bangladesh. Participants will take the medication once daily for 12 weeks, with doses adjusted as needed. Researchers will measure changes in symptoms us…
Phase: PHASE4 • Sponsor: Sher-E-Bangla Medical College • Aim: Disease control
Last updated Jun 26, 2026 13:23 UTC